I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Table_1_Empagliflozin suppresses mitochondrial reactive oxy..:
Takuya Koizumi
;
Masaya Watanabe
;
Takashi Yokota
...
doi:10.3389/fcvm.2023.1005408.s002. , 2023
Link:
https://doi.org/10.3389/fcvm.2023.1005408.s002
RT Journal T1
Table_1_Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats.DOCX
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_22013354&Exemplar=1&LAN=DE A1 Takuya Koizumi A1 Masaya Watanabe A1 Takashi Yokota A1 Masumi Tsuda A1 Haruka Handa A1 Jiro Koya A1 Kotaro Nishino A1 Daishiro Tatsuta A1 Hiroyuki Natsui A1 Takahide Kadosaka A1 Taro Koya A1 Motoki Nakao A1 Hikaru Hagiwara A1 Rui Kamada A1 Taro Temma A1 Shinya Tanaka A1 Toshihisa Anzai YR 2023 K1 Cardiology K1 Cardiology (incl. Cardiovascular Diseases) K1 Cardiorespiratory Medicine and Haematology not elsewhere classified K1 empagliflozin K1 diabetes K1 mitochondria K1 reactive oxygen species K1 SGLT2 inhibitor JF doi:10.3389/fcvm.2023.1005408.s002 LK http://dx.doi.org/https://doi.org/10.3389/fcvm.2023.1005408.s002 DO https://doi.org/10.3389/fcvm.2023.1005408.s002 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)